restor3d Launches Aeros Modular Stem Ankle System
DURHAM, N.C., April 2, 2026 restor3d, Inc., a leader in 3D-printed orthopedic medical devices, announced the full commercial release...
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody NSCLC Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
DURHAM, N.C., April 2, 2026 restor3d, Inc., a leader in 3D-printed orthopedic medical devices, announced the full commercial release...
BESANÇON, France, March 24, 2026 Pixee Medical has announced the U.S. launch of its Knee+ NexSight augmented reality (AR)...
Dateline – FORT LAUDERDALE, Fla., Feb. 5, 2026 — Spinal Resources Inc. announced that the U.S. Food and Drug...
UNITED STATES | January 27, 2026 — ABANZA, a medical technology company focused on advancing soft-tissue fixation solutions, announced...
